According to Future Market Insights research, during the projected period, the global cryopreservation freezers market is expected to grow at a CAGR of 6.5%. The market value is projected to increase from US$ 585.0 Million in 2023 to US$ 1.1 Billion by 2033. The cryopreservation freezers market was valued at US$ 552.3 Million at the end of 2022 and is anticipated to exhibit Y-o-Y growth of 5.9% in 2023.
Market Outlook:
Data Points | Market Insights |
---|---|
Market Value 2022 | US$ 552.3 Million |
Market Value 2023 | US$ 585.0 Million |
Market Value 2033 | US$ 1.1 Billion |
CAGR 2023 to 2033 | 6.5% |
Market Share of Top 5 Countries | 55.8% |
Key Companies List | ACMAS Technologies Pvt. Ltd.; Air Water Inc.; ARCTIKO AS; Aucma Co. Ltd; Avantor Inc.; BioLife Solutions, Inc.; Brooks Automation Inc.; Chart Industries Inc.; ZHONGKE MEILING CRYOGENICS CO. LTD.; Froilabo; Haier Biomedical; Hamilton Thorne Ltd.; Helmer Scientific Inc.; Panasonic Holdings Corp.; PHC Holdings Corp.; Scientific Research Instruments Co Pvt Ltd; Thermo Fisher Scientific Inc.; Wuxi Guanya Refrigeration Technology Co. Ltd.; Scimed Asia Pte Ltd.; and Stericox India Pvt. Ltd. |
The storage and preservation of biological samples have been revolutionized by cryopreservation freezers, which have become an indispensable tools in the healthcare industry. These freezers provide a practical method for maintaining the viability and integrity of cells, tissues, and organs while storing them for an extended period at very low temperatures.
The need for cryopreservation freezers has significantly increased because of developments in medical research and treatments. To ensure ideal preservation conditions, these freezers offer accurate temperature control, effective cooling, and cutting-edge cryogenic monitoring systems (CMS).
The cryopreservation freezers’ subfreezing temperature varies from below -80°C and typically below -160°C to maintain the biologics.
Cryopreservation freezers have been embraced by the healthcare industry for a variety of uses, including organ transplantation; stem cell research, and pharmaceutical development. They are essential in the search for groundbreaking medical discoveries because of their capacity to keep biological material in a stable form.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global cryopreservation freezers market recorded a historic CAGR of 5.4% in the last 5 years from 2017 to 2022. The global cryopreservation freezers market contribute around 15.0% to the global biomedical refrigerator and freezers market value at around US$ 3.6 Billion in 2022.
The market for cryopreservation freezers in the healthcare industry is being significantly driven by increased research into genetic disorders. Various medical diseases are brought on by genetic disorders, due to anomalies in a person's DNA or genes.
Understanding the underlying genetic pathways, creating tailored treatments, and improving diagnostics for various disorders are the goals of this field of study. By permitting the storage and preservation of genetic material, including DNA, RNA, and cells, for analysis and testing, cryopreservation freezers play a significant part in this study.
Cryopreservation freezers are necessary because genetic material is sensitive and needs to be kept stable and intact at extremely low temperatures. The long-term storage of genetic samples without degradation is ensured by these freezers, which offer a regulated environment with temperatures as low as -150°C or lower. Researchers can preserve the integrity of the samples over long periods of time by keeping genetic material in cryopreservation freezers, making subsequent analysis and experiments easier.
Cryopreservation freezers also provide improved sample security by lowering the possibility of contamination or sample loss. They offer chambers that are both airtight and temperature-controlled, shielding the genetic material from outside contamination and maintaining it in a stable form.
The expanding understanding of the role genetics plays in human health and disease is what is driving the surge in research into genetic disorders. New research and diagnostic opportunities for genetic illnesses have been made possible by improvements in genomic analysis technologies and genetic sequencing technologies. The need for cryopreservation freezers to store and preserve genetic material for in-depth study and testing is growing as researchers learn more about the genetic basis of diseases.
The demand for cryopreservation freezers, which are vital tools in the healthcare industry and enable researchers to store and preserve genetic material accurately and securely for advancing the understanding of genetic disorders and developing targeted therapies, is generally driven by the increased research into genetic disorders.
The cryogenic freezers industry is primarily driven by advancements in technology. Cryopreservation freezer technology has undergone constant invention and development, which has greatly increased its effectiveness, dependability, and user-friendliness. These developments have produced cutting-edge features and capabilities that meet the changing demands of the healthcare sector.
Improvements in temperature control systems due to technology include the adoption of sophisticated refrigeration methods and accurate temperature monitoring. Improved chilling techniques guarantee quick and even freezing of samples, lowering the chance of damage or cell death. Additionally, automated sample handling systems simplify the process of storing and retrieving samples, increasing operational effectiveness overall.
As per the standards of biological product manufacturing, it needs specific temperature-controlled rooms to avoid contamination there are several emerging players with their innovations to tackle this issue.
This makes the cryopreservation freezer a perfect alternative for laboratories and other organizations that need to store and maintain susceptible temperature to exchange products in a contamination-free environment. These environments include crucial cleanrooms and associated controlled conditions, such as sterile medicine and biological product manufacture using aseptic processing.
The implementation of advanced monitoring and alarm systems is another noteworthy development. These systems offer real-time information on temperature, humidity, and other crucial parameters, enabling quick action in the event of any anomalies and guaranteeing the integrity and security of stored samples.
In general, cryogenic freezer technology advances promote market expansion by offering more dependable, effective, and user-friendly solutions that meet the changing needs of the healthcare sector for sample storage and preservation.
Cryopreservation freezers' high price is a significant market growth inhibitor. First off, many potential consumers may not be able to afford these freezers due to the significant initial expenditure needed to buy and install them.
Subsequently, the ongoing costs of running cryopreservation freezers, such as energy, liquid nitrogen (LN), and routine maintenance, add to the overall financial burden. By doing this, the market is limited to businesses or facilities with adequate financial resources.
Likewise, the high price makes it difficult for smaller-scale or resource-constrained settings, like clinics or research institutions with tight budgets, to employ cryopreservation technology. As a result, the barrier created by cryopreservation freezers' high price limits the market growth potential for these devices.
The U.S. dominates the global market with a total market share of over 32.2% in 2022 and is projected to continue experiencing high growth throughout the forecast period.
The United States market for cryopreservation freezers is significantly influenced by organ transplantation. As an effective therapy option for patients with advanced organ failure, the demand for organ transplantation is rapidly rising.
In this procedure, cryopreservation freezers are essential because they retain the viability and functionality of the preserved organs at extremely low temperatures until they can be transplanted into the recipient.
The risk of harm or deterioration is reduced because of the controlled atmosphere these freezers offer, which guarantees the best preservation conditions for organs. The demand for effective and dependable cryopreservation freezers grows as the frequency of organ transplant procedures increases, propelling the expansion of the cryopreservation freezers market in the United States.
Germany holds a market share of over 6.8% in the global market in 2022.
The cryogenic freezers industry is significantly fueled by developments in biomedical research in Germany. The biomedical research industry in Germany is strong and forward thinking, with a concentration on cutting-edge fields including genetics, regenerative medicine, and customized healthcare.
These developments increase the demand for cryogenic freezers, which are necessary for preserving and storing priceless biological samples used in scientific research.
Researchers can preserve the integrity and viability of cells, tissues, and genetic material for extended periods by using cryogenic freezers. They offer accurate temperature regulation, making sure the samples are kept at the extremely low temperatures necessary for their preservation.
This enables scientists in Germany to carry out extensive and protracted studies that result in advances in the knowledge of chronic diseases, the creation of novel treatments, and customized medicine.
Cryogenic freezer demand is increasing as biomedical research flourishes in Germany. These freezers provide the infrastructure required to meet the storage and preservation requirements of various research facilities, academic institutions, and biotechnology firms, speeding scientific advancements and fueling market expansion in the German cryogenic freezers market.
China holds a 6.3% share in the global market share in 2022.
The market for cryogenic freezers is significantly being driven by China's growing stem cell banking industry. Due to the improvements in stem cell research and the increased awareness of the therapeutic potential of stem cells, China has seen a significant rise in stem cell banking.
As they offer the necessary ultra-low temperature storage conditions needed to keep stem cells viable and functional, cryogenic freezers play a significant part in stem cell banking. These freezers make it possible to preserve stem cells over an extended period, guaranteeing their accessibility for prospective treatments and regenerative therapies.
There is a growing demand for dependable cryogenic freezers that provide accurate temperature control, effective cooling, and cutting-edge monitoring systems in China as stem cell banking becomes more and more popular.
As medical facilities, stem cell banks and research facilities invest in cutting-edge freezer technology to support the developing stem cell banking sector and satisfy the needs of stem cells for storage and preservation, the cryogenic freezers market in China is expanding.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Tunnel freezer hold a revenue share of 41.2% in 2022, and the same trend is being followed over the forecasted period.
Due to its enormous capacity, effective freezing technique, and suitability for large-scale preservation requirements, the tunnel freezer segment leads the cryopreservation freezers market in the healthcare industry, making it a favored choice for keeping biological samples and medical items.
Medical and healthcare settings hold a market share of 42.3% in 2022, within the forecasted period.
Since these facilities have a greater need for preserving and storing biological samples, vaccines, pharmaceuticals, and other medical products, specialized freezer solutions are required, the medical and healthcare settings segment dominates the end-user segment in the market for cryopreservation freezers in the healthcare industry.
Growing demand for technologically advanced products in the field of cryopreservation freezers market has led companies to adopt strategies like plant expansion, increasing research and development and collaborations.
Similarly, recent developments related to companies in the cryopreservation freezers market have been tracked by the team at Future Market Insights, which are available in the full report.
Attributes | Details |
---|---|
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2017 to 2022 |
Market Analysis | US$ Million for Value, Units for Volume |
Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa |
Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, UK, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Türkiye, GCC Countries, South Africa, and Northern Africa |
Key Market Segments Covered | Product, End User and Region |
Key Companies Profiled | ACMAS Technologies Pvt. Ltd.; Air Water Inc.; ARCTIKO AS; Aucma Co. Ltd; Avantor Inc.; BioLife Solutions, Inc.; Brooks Automation Inc.; Chart Industries Inc.; ZHONGKE MEILING CRYOGENICS CO. LTD.; Froilabo; Haier Biomedical; Hamilton Thorne Ltd.; Helmer Scientific Inc.; Panasonic Holdings Corp.; PHC Holdings Corp.; Scientific Research Instruments Co Pvt Ltd; Thermo Fisher Scientific Inc.; Wuxi Guanya Refrigeration Technology Co. Ltd.; Scimed Asia Pte Ltd.; Stericox India Pvt. Ltd. |
Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
Pricing | Available upon Request |
The market is predicted to attain a valuation of US$ 585.0 million in 2023.
The growth potential of the market is 6.5% through 2033.
The market is expected to reach US$ 1.1 billion by 2033.
The market exhibited a 5.4% CAGR from 2017 to 2022.
ARCTIKO AS, Aucma Co. Ltd, and Avantor Inc. are the key market players.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusion and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Innovation/Development Trends 4. Value Added Insights 4.1. Adoption Rate/Usage Analysis for 4.2. Regulatory Scenario 4.3. PESTLE Analysis 4.4. Porter's Analysis 4.5. Technology Assessment 4.6. Recent Product Approvals/Launches 4.7. Value Chain Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global Healthcare Expenditure Outlook 5.1.2. Cold Storage Market Analysis 5.2. Forecast Factors - Relevance & Impact 5.2.1. Awareness of Cryopreservation Freezers 5.2.2. Increasing Prevalence of Chronic Disease 5.2.3. Advancements in Biomedical Research 5.2.4. Growing Investment in Healthcare Expenditure 5.2.5. New Product Launch 5.2.6. Top Companies’ Historical Growth 5.2.7. Product Cost 5.2.8. Strategic Collaboration and Partnership 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. Global Market Volume (Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033 6.1. Historical Market Volume (Units) Analysis, 2017 to 2022 6.2. Current and Future Market Volume (Units) Projections, 2023 to 2033 6.2.1. Y-o-Y Growth Trend Analysis 7. Global Market - Pricing Analysis 7.1. Regional Pricing Analysis By Product 7.2. Pricing Break-up 7.2.1. Manufacturer Level Pricing 7.2.2. Distributor Level Pricing 7.3. Global Average Pricing Analysis 7.4. Pricing Assumptions 8. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033 8.1. Revenue Opportunity Scenario- Likely/Conservative/Optimistic 8.2. Historical Market Value (US$ Million) Analysis, 2017 to 2022 8.3. Current and Future Market Value (US$ Million) Projections, 2023 to 2033 8.3.1. Y-o-Y Growth Trend Analysis 8.3.2. Absolute $ Opportunity Analysis 9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Product, 2017 to 2022 9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Product, 2023 to 2033 9.3.1. Tunnel Freezer 9.3.2. IQF Freezer 9.3.3. Immersion Freezer 9.3.4. Spiral Freezer 9.3.5. Others 9.4. Market Attractiveness Analysis by Product 10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by End User 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) Analysis by End User , 2017 to 2022 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast by End User , 2023 to 2033 10.3.1. Medical and Healthcare settings 10.3.2. Bio-pharma companies 10.3.3. Blood Banks 10.3.4. Research Institutes 10.3.5. Others 10.4. Market Attractiveness Analysis by End User 11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 11.1. Introduction 11.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Region, 2017 to 2022 11.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Region, 2023 to 2033 11.3.1. North America 11.3.2. Latin America 11.3.3. Europe 11.3.4. East Asia 11.3.5. South Asia 11.3.6. Oceania 11.3.7. Middle East & Africa 11.4. Market Attractiveness Analysis by Region 12. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 12.1. Introduction 12.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022 12.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 12.3.1. By Country 12.3.1.1. U.S. 12.3.1.2. Canada 12.3.2. By Product 12.3.3. By End User 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Product 12.4.3. By End User 12.5. Market Trends 12.6. Drivers and Restraints - Impact Analysis 12.7. Country Level Analysis & Forecast 12.7.1. U.S Market 12.7.1.1. Introduction 12.7.1.2. Market Analysis and Forecast by Market Taxonomy 12.7.1.2.1. By Product 12.7.1.2.2. By End User 12.7.2. Canada Market 12.7.2.1. Introduction 12.7.2.2. Market Analysis and Forecast by Market Taxonomy 12.7.2.2.1. By Product 12.7.2.2.2. By End User 13. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 13.1. Introduction 13.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022 13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 13.3.1. By Country 13.3.1.1. Brazil 13.3.1.2. Mexico 13.3.1.3. Argentina 13.3.1.4. Rest of Latin America 13.3.2. By Product 13.3.3. By End User 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Product 13.4.3. By End User 13.5. Market Trends 13.6. Drivers and Restraints - Impact Analysis 13.7. Country Level Analysis & Forecast 13.7.1. Brazil Market Analysis 13.7.1.1. Introduction 13.7.1.2. Market Analysis and Forecast by Market Taxonomy 13.7.1.2.1. By Product 13.7.1.2.2. By End User 13.7.2. Mexico Market Analysis 13.7.2.1. Introduction 13.7.2.2. Market Analysis and Forecast by Market Taxonomy 13.7.2.2.1. By Product 13.7.2.2.2. By End User 13.7.3. Argentina Market Analysis 13.7.3.1. Introduction 13.7.3.2. Market Analysis and Forecast by Market Taxonomy 13.7.3.2.1. By Product 13.7.3.2.2. By End User 14. Europe Market 2017 - 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022 14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 14.3.1. By Country 14.3.1.1. Germany 14.3.1.2. France 14.3.1.3. Spain 14.3.1.4. Italy 14.3.1.5. BENELUX 14.3.1.6. U.K. 14.3.1.7. Russia 14.3.1.8. Rest of Europe 14.3.2. By Product 14.3.3. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.4.3. By End User 14.5. Market Trends 14.6. Drivers and Restraints - Impact Analysis 14.7. Country Level Analysis & Forecast 14.7.1. Germany Market Analysis 14.7.1.1. Introduction 14.7.1.2. Market Analysis and Forecast by Market Taxonomy 14.7.1.2.1. By Product 14.7.1.2.2. By End User 14.7.2. France Market Analysis 14.7.2.1. Introduction 14.7.2.2. Market Analysis and Forecast by Market Taxonomy 14.7.2.2.1. By Product 14.7.2.2.2. By End User 14.7.3. Spain Market Analysis 14.7.3.1. Introduction 14.7.3.2. Market Analysis and Forecast by Market Taxonomy 14.7.3.2.1. By Product 14.7.3.2.2. By End User 14.7.4. Italy Market Analysis 14.7.4.1. Introduction 14.7.4.2. Market Analysis and Forecast by Market Taxonomy 14.7.4.2.1. By Product 14.7.4.2.2. By End User 14.7.5. BENELUX Market Analysis 14.7.5.1. Introduction 14.7.5.2. Market Analysis and Forecast by Market Taxonomy 14.7.5.2.1. By Product 14.7.5.2.2. By End User 14.7.6. U.K Market Analysis 14.7.6.1. Introduction 14.7.6.2. Market Analysis and Forecast by Market Taxonomy 14.7.6.2.1. By Product 14.7.6.2.2. By End User 14.7.7. Russia Market Analysis 14.7.7.1. Introduction 14.7.7.2. Market Analysis and Forecast by Market Taxonomy 14.7.7.2.1. By Product 14.7.7.2.2. By End User 15. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022 15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 15.3.1. By Country 15.3.1.1. China 15.3.1.2. Japan 15.3.1.3. South Korea 15.3.2. By Product 15.3.3. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By End User 15.5. Market Trends 15.6. Drivers and Restraints - Impact Analysis 15.7. Country Level Analysis & Forecast 15.7.1. China Market Analysis 15.7.1.1. Introduction 15.7.1.2. Market Analysis and Forecast by Market Taxonomy 15.7.1.2.1. By Product 15.7.1.2.2. By End User 15.7.2. Japan Market Analysis 15.7.2.1. Introduction 15.7.2.2. Market Analysis and Forecast by Market Taxonomy 15.7.2.2.1. By Product 15.7.2.2.2. By End User 15.7.3. South Korea Market Analysis 15.7.3.1. Introduction 15.7.3.2. Market Analysis and Forecast by Market Taxonomy 15.7.3.2.1. By Product 15.7.3.2.2. By End User 16. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022 16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Indonesia 16.3.1.3. Thailand 16.3.1.4. Malaysia 16.3.1.5. Rest of South Asia 16.3.2. By Product 16.3.3. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By End User 16.5. Market Trends 16.6. Drivers and Restraints - Impact Analysis 16.7. Country Level Analysis & Forecast 16.7.1. India Market Analysis 16.7.1.1. Introduction 16.7.1.2. Market Analysis and Forecast by Market Taxonomy 16.7.1.2.1. By Product 16.7.1.2.2. By End User 16.7.2. Indonesia Market Analysis 16.7.2.1. Introduction 16.7.2.2. Market Analysis and Forecast by Market Taxonomy 16.7.2.2.1. By Product 16.7.2.2.2. By End User 16.7.3. Thailand Market Analysis 16.7.3.1. Introduction 16.7.3.2. Market Analysis and Forecast by Market Taxonomy 16.7.3.2.1. By Product 16.7.3.2.2. By End User 16.7.4. Malaysia Market Analysis 16.7.4.1. Introduction 16.7.4.2. Market Analysis and Forecast by Market Taxonomy 16.7.4.2.1. By Product 16.7.4.2.2. By End User 17. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022 17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 17.3.1. By Country 17.3.1.1. Australia 17.3.1.2. New Zealand 17.3.2. By Product 17.3.3. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By End User 17.5. Market Trends 17.6. Drivers and Restraints - Impact Analysis 17.7. Country Level Analysis & Forecast 17.7.1. Australia Market Analysis 17.7.1.1. Introduction 17.7.1.2. Market Analysis and Forecast by Market Taxonomy 17.7.1.2.1. By Product 17.7.1.2.2. By End User 17.7.2. New Zealand Market Analysis 17.7.2.1. Introduction 17.7.2.2. Market Analysis and Forecast by Market Taxonomy 17.7.2.2.1. By Product 17.7.2.2.2. By End User 18. Middle East & Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033 18.1. Introduction 18.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022 18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 18.3.1. By Country 18.3.1.1. GCC Countries 18.3.1.2. Türkiye 18.3.1.3. Northern Africa 18.3.1.4. South Africa 18.3.1.5. Rest of MEA 18.3.2. By Product 18.3.3. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Product 18.4.3. By End User 18.5. Market Trends 18.6. Drivers and Restraints - Impact Analysis 18.7. Country Level Analysis & Forecast 18.7.1. GCC Countries Market Analysis 18.7.1.1. Introduction 18.7.1.2. Market Analysis and Forecast by Market Taxonomy 18.7.1.2.1. By Product 18.7.1.2.2. By End User 18.7.2. Türkiye Market Analysis 18.7.2.1. Introduction 18.7.2.2. Market Analysis and Forecast by Market Taxonomy 18.7.2.2.1. By Product 18.7.2.2.2. By End User 18.7.3. Northern Africa Market Analysis 18.7.3.1. Introduction 18.7.3.2. Market Analysis and Forecast by Market Taxonomy 18.7.3.2.1. By Product 18.7.3.2.2. By End User 18.7.4. South Africa Market Analysis 18.7.4.1. Introduction 18.7.4.2. Market Analysis and Forecast by Market Taxonomy 18.7.4.2.1. By Product 18.7.4.2.2. By End User 19. Market Structure Analysis 19.1. Market Analysis by Tier of Companies 19.2. Market Share Analysis of Top Players 19.3. Market Presence Analysis 19.3.1. Regional footprint of Players 19.3.2. Product footprint by Players 19.3.3. Channel footprint by Players 20. Competition Analysis 20.1. Competition Dashboard 20.2. Competition Benchmarking 20.3. Competition Deep Dive 20.3.1. ACMAS Technologies Pvt. Ltd. 20.3.1.1. Overview 20.3.1.2. Product Portfolio 20.3.1.3. Key Financials 20.3.1.4. Sales Footprint 20.3.1.5. SWOT Analysis 20.3.1.6. Key Developments 20.3.1.7. Strategy Overview 20.3.1.7.1. Channel Strategy 20.3.1.7.2. Marketing Strategy 20.3.1.7.3. Product Strategy 20.3.2. Air Water Inc. 20.3.2.1. Overview 20.3.2.2. Product Portfolio 20.3.2.3. Key Financials 20.3.2.4. Sales Footprint 20.3.2.5. SWOT Analysis 20.3.2.6. Key Developments 20.3.2.7. Strategy Overview 20.3.2.7.1. Channel Strategy 20.3.2.7.2. Marketing Strategy 20.3.2.7.3. Product Strategy 20.3.3. ARCTIKO AS 20.3.3.1. Overview 20.3.3.2. Product Portfolio 20.3.3.3. Key Financials 20.3.3.4. Sales Footprint 20.3.3.5. SWOT Analysis 20.3.3.6. Key Developments 20.3.3.7. Strategy Overview 20.3.3.7.1. Channel Strategy 20.3.3.7.2. Marketing Strategy 20.3.3.7.3. Product Strategy 20.3.4. Aucma Co. Ltd 20.3.4.1. Overview 20.3.4.2. Product Portfolio 20.3.4.3. Key Financials 20.3.4.4. Sales Footprint 20.3.4.5. SWOT Analysis 20.3.4.6. Key Developments 20.3.4.7. Strategy Overview 20.3.4.7.1. Channel Strategy 20.3.4.7.2. Marketing Strategy 20.3.4.7.3. Product Strategy 20.3.5. Avantor Inc. 20.3.5.1. Overview 20.3.5.2. Product Portfolio 20.3.5.3. Key Financials 20.3.5.4. Sales Footprint 20.3.5.5. SWOT Analysis 20.3.5.6. Key Developments 20.3.5.7. Strategy Overview 20.3.5.7.1. Channel Strategy 20.3.5.7.2. Marketing Strategy 20.3.5.7.3. Product Strategy 20.3.6. BioLife Solutions, Inc. 20.3.6.1. Overview 20.3.6.2. Product Portfolio 20.3.6.3. Key Financials 20.3.6.4. Sales Footprint 20.3.6.5. SWOT Analysis 20.3.6.6. Key Developments 20.3.6.7. Strategy Overview 20.3.6.7.1. Channel Strategy 20.3.6.7.2. Marketing Strategy 20.3.6.7.3. Product Strategy 20.3.7. Brooks Automation Inc. 20.3.7.1. Overview 20.3.7.2. Product Portfolio 20.3.7.3. Key Financials 20.3.7.4. Sales Footprint 20.3.7.5. SWOT Analysis 20.3.7.6. Key Developments 20.3.7.7. Strategy Overview 20.3.7.7.1. Channel Strategy 20.3.7.7.2. Marketing Strategy 20.3.7.7.3. Product Strategy 20.3.8. Chart Industries Inc. 20.3.8.1. Overview 20.3.8.2. Product Portfolio 20.3.8.3. Key Financials 20.3.8.4. Sales Footprint 20.3.8.5. SWOT Analysis 20.3.8.6. Key Developments 20.3.8.7. Strategy Overview 20.3.8.7.1. Channel Strategy 20.3.8.7.2. Marketing Strategy 20.3.8.7.3. Product Strategy 20.3.9. ZHONGKE MEILING CRYOGENICS CO. LTD. 20.3.9.1. Overview 20.3.9.2. Product Portfolio 20.3.9.3. Key Financials 20.3.9.4. Sales Footprint 20.3.9.5. SWOT Analysis 20.3.9.6. Key Developments 20.3.9.7. Strategy Overview 20.3.9.7.1. Channel Strategy 20.3.9.7.2. Marketing Strategy 20.3.9.7.3. Product Strategy 20.3.10. Froilabo 20.3.10.1. Overview 20.3.10.2. Product Portfolio 20.3.10.3. Key Financials 20.3.10.4. Sales Footprint 20.3.10.5. SWOT Analysis 20.3.10.6. Key Developments 20.3.10.7. Strategy Overview 20.3.10.7.1. Channel Strategy 20.3.10.7.2. Marketing Strategy 20.3.10.7.3. Product Strategy 20.3.11. Haier Biomedical 20.3.11.1. Overview 20.3.11.2. Product Portfolio 20.3.11.3. Key Financials 20.3.11.4. Sales Footprint 20.3.11.5. SWOT Analysis 20.3.11.6. Key Developments 20.3.11.7. Strategy Overview 20.3.11.7.1. Channel Strategy 20.3.11.7.2. Marketing Strategy 20.3.11.7.3. Product Strategy 20.3.12. Hamilton Thorne Ltd. 20.3.12.1. Overview 20.3.12.2. Product Portfolio 20.3.12.3. Key Financials 20.3.12.4. Sales Footprint 20.3.12.5. SWOT Analysis 20.3.12.6. Key Developments 20.3.12.7. Strategy Overview 20.3.12.7.1. Channel Strategy 20.3.12.7.2. Marketing Strategy 20.3.12.7.3. Product Strategy 20.3.13. Helmer Scientific Inc. 20.3.13.1. Overview 20.3.13.2. Product Portfolio 20.3.13.3. Key Financials 20.3.13.4. Sales Footprint 20.3.13.5. SWOT Analysis 20.3.13.6. Key Developments 20.3.13.7. Strategy Overview 20.3.13.7.1. Channel Strategy 20.3.13.7.2. Marketing Strategy 20.3.13.7.3. Product Strategy 20.3.14. Panasonic Holdings Corp. 20.3.14.1. Overview 20.3.14.2. Product Portfolio 20.3.14.3. Key Financials 20.3.14.4. Sales Footprint 20.3.14.5. SWOT Analysis 20.3.14.6. Key Developments 20.3.14.7. Strategy Overview 20.3.14.7.1. Channel Strategy 20.3.14.7.2. Marketing Strategy 20.3.14.7.3. Product Strategy 20.3.15. PHC Holdings Corp. 20.3.15.1. Overview 20.3.15.2. Product Portfolio 20.3.15.3. Key Financials 20.3.15.4. Sales Footprint 20.3.15.5. SWOT Analysis 20.3.15.6. Key Developments 20.3.15.7. Strategy Overview 20.3.15.7.1. Channel Strategy 20.3.15.7.2. Marketing Strategy 20.3.15.7.3. Product Strategy 20.3.16. Scientific Research Instruments Co Pvt Ltd 20.3.16.1. Overview 20.3.16.2. Product Portfolio 20.3.16.3. Key Financials 20.3.16.4. Sales Footprint 20.3.16.5. SWOT Analysis 20.3.16.6. Key Developments 20.3.16.7. Strategy Overview 20.3.16.7.1. Channel Strategy 20.3.16.7.2. Marketing Strategy 20.3.16.7.3. Product Strategy 20.3.17. Thermo Fisher Scientific Inc. 20.3.17.1. Overview 20.3.17.2. Product Portfolio 20.3.17.3. Key Financials 20.3.17.4. Sales Footprint 20.3.17.5. SWOT Analysis 20.3.17.6. Key Developments 20.3.17.7. Strategy Overview 20.3.17.7.1. Channel Strategy 20.3.17.7.2. Marketing Strategy 20.3.17.7.3. Product Strategy 20.3.18. Wuxi Guanya Refrigeration Technology Co. Ltd. 20.3.18.1. Overview 20.3.18.2. Product Portfolio 20.3.18.3. Key Financials 20.3.18.4. Sales Footprint 20.3.18.5. SWOT Analysis 20.3.18.6. Key Developments 20.3.18.7. Strategy Overview 20.3.18.7.1. Channel Strategy 20.3.18.7.2. Marketing Strategy 20.3.18.7.3. Product Strategy 20.3.19. Scimed Asia Pte Ltd. 20.3.19.1. Overview 20.3.19.2. Product Portfolio 20.3.19.3. Key Financials 20.3.19.4. Sales Footprint 20.3.19.5. SWOT Analysis 20.3.19.6. Key Developments 20.3.19.7. Strategy Overview 20.3.19.7.1. Channel Strategy 20.3.19.7.2. Marketing Strategy 20.3.19.7.3. Product Strategy 20.3.20. Stericox India Pvt. Ltd. 20.3.20.1. Overview 20.3.20.2. Product Portfolio 20.3.20.3. Key Financials 20.3.20.4. Sales Footprint 20.3.20.5. SWOT Analysis 20.3.20.6. Key Developments 20.3.20.7. Strategy Overview 20.3.20.7.1. Channel Strategy 20.3.20.7.2. Marketing Strategy 20.3.20.7.3. Product Strategy 21. Assumptions and Acronyms Used 22. Research Methodology
Explore Healthcare Insights
View Reports